Form 4 for ACH ACCENDRA HEALTH INC/VA/
Accepted 2021-08-13 00:00:00 ET · period of report 2021-08-11 · accession 0000075252-21-000139 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-08-13 | 2021-08-11 | ACH | Pesicka Edward A | Pres, CEO, Dir | S - Sale | $38.65 | -31.8K | 1.34M | -2% | -$1.23M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-11 | S | D | 23,918 | $38.63 | 1,320,426 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 5, 2021. (F3) Weighted average of the sale price range of $38.08 through $39.06. |
| 2 | Common | Common Stock | 2021-08-11 | S | D | 7,867 | $38.72 | 1,344,344 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 5, 2021. (F2) Weighted average of the sale price range of $38.10 through $39.09. |